Nevertheless, retrospective biobank studies on asymptomatic pre-RA individuals showed that RF and ACPA levels positivity increase as time remaining to symptom onset and RA diagnosis decreases [[74], [75], [76]], indicating that it may be relevant to monitor autoantibody levels in the at-risk phase. This evidence concerns the gene PRTN3 and rheumatoid arthritis.